Publications:

POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.

Clinical And Translational Medicine

Chen, Yan-Xing YX; Wang, Zi-Xian ZX; Yuan, Shu-Qiang SQ; Jiang, Teng-Jia TJ; Huang, You-Sheng YS; Xu, Rui-Hua RH; Wang, Feng F; Zhao, Qi Q

Publication Date: 2021-09

Variant appearance in text: POLE: Q1285K

PubMed Link: 34586735

Variant Present in the following documents:

• CTM2-11-e524-s001.xlsx, sheet 6
• CTM2-11-e524-s001.xlsx, sheet 2

View BVdb publication page

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.

Bmc Medical Genomics

Lee, Eunjin E; Lee, Ji Won JW; Lee, Boram B; Park, Kyunghee K; Shim, Joonho J; Yoo, Keon Hee KH; Koo, Hong Hoe HH; Sung, Ki Woong KW; Park, Woong-Yang WY

Publication Date: 2020-11-10

Variant appearance in text: POLE: Q1285K

PubMed Link: 33172452

Variant Present in the following documents:

• Main text
• 12920_2020_Article_819.pdf

View BVdb publication page